Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial published ...

Home; Articles; The dopaminergic effects of esketamine are mediated by a dual mechanism involving glutamate and opioid receptors ...